Tihui Fu

2.1k total citations · 1 hit paper
21 papers, 1.7k citations indexed

About

Tihui Fu is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Tihui Fu has authored 21 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 13 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Tihui Fu's work include Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Tihui Fu is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Tihui Fu collaborates with scholars based in United States, Australia and Canada. Tihui Fu's co-authors include Kui Shin Voo, Padmanee Sharma, Helen Y. Wang, Rongfu Wang, Qiuming He, Guangyong Peng, Zhong Guo, Yanchun Li, Daniel Wang and Yukiko Kiniwa and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Tihui Fu

21 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toll-Like Receptor 8-Mediated Reversal of CD4 ⁺ Regulatory T Cell Function

2005 603 citations Guangyong Peng, Zhong Guo et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tihui Fu United States	16	1.2k	743	387	170	109	21	1.7k
Hong Qin United States	21	1.1k 0.9×	704 0.9×	501 1.3×	86 0.5×	124 1.1×	65	1.7k
Tao Zou United States	13	1.8k 1.4×	907 1.2×	436 1.1×	294 1.7×	78 0.7×	18	2.3k
Christian A. Schmidt Germany	17	813 0.7×	434 0.6×	214 0.6×	234 1.4×	154 1.4×	47	1.5k
Victor Levitsky Sweden	17	1.1k 0.8×	627 0.8×	313 0.8×	116 0.7×	49 0.4×	37	1.5k
Deepali V. Sawant United States	16	1.2k 1.0×	576 0.8×	331 0.9×	114 0.7×	76 0.7×	20	1.7k
Katharina Willimann Switzerland	12	2.4k 1.9×	835 1.1×	239 0.6×	197 1.2×	72 0.7×	14	2.8k
Annamalai Selvakumar United States	23	1.7k 1.3×	487 0.7×	343 0.9×	137 0.8×	40 0.4×	56	2.0k
Michael Gombert Germany	17	1.3k 1.0×	302 0.4×	249 0.6×	106 0.6×	145 1.3×	28	1.8k
Mirjana Urosevic Switzerland	23	1.3k 1.1×	511 0.7×	346 0.9×	468 2.8×	235 2.2×	46	2.0k
Dai Izawa Japan	12	893 0.7×	502 0.7×	324 0.8×	85 0.5×	79 0.7×	14	1.4k

Countries citing papers authored by Tihui Fu

Since Specialization

Citations

This map shows the geographic impact of Tihui Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tihui Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tihui Fu more than expected).

Fields of papers citing papers by Tihui Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tihui Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tihui Fu. The network helps show where Tihui Fu may publish in the future.

Co-authorship network of co-authors of Tihui Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Tihui Fu. A scholar is included among the top collaborators of Tihui Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tihui Fu. Tihui Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Shi, Lewis Z., Sangeeta Goswami, Tihui Fu, et al.. (2019). Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner. Cancer Immunology Research. 7(11). 1803–1812. 35 indexed citations

2.

Hailemichael, Yared, Amber N. Woods, Tihui Fu, et al.. (2018). Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. Journal of Clinical Investigation. 128(4). 1338–1354. 62 indexed citations

3.

Bhattacharya, Sabyasachi, Christopher Matheny, Niranjan Yanamandra, et al.. (2018). Synergy of TLR4 agonist GSK1795091, an innate immune activator, with agonistic antibody against co-stimulatory immune checkpoint molecule OX40 in cancer immunotherapy.. Journal of Clinical Oncology. 36(15_suppl). 12055–12055. 8 indexed citations

4.

Metzger, Todd C., Hua Long, Shobha Potluri, et al.. (2016). ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40–Mediated Tumor Rejection. Cancer Research. 76(13). 3684–3689. 49 indexed citations

5.

Shi, Lewis Z., Tihui Fu, Baoxiang Guan, et al.. (2016). Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy. Nature Communications. 7(1). 12335–12335. 81 indexed citations

6.

Chen, Hong, Tihui Fu, Woong‐Kyung Suh, et al.. (2013). CD4 T Cells Require ICOS-Mediated PI3K Signaling to Increase T-Bet Expression in the Setting of Anti-CTLA-4 Therapy. Cancer Immunology Research. 2(2). 167–176. 44 indexed citations

7.

Fu, Tihui, Qiuming He, & Padmanee Sharma. (2011). The ICOS/ICOSL Pathway Is Required for Optimal Antitumor Responses Mediated by Anti–CTLA-4 Therapy. Cancer Research. 71(16). 5445–5454. 193 indexed citations

8.

Fu, Tihui, et al.. (2011). ICOS/ICOSL経路は,抗CTLA-4療法によってもたらされる最適な抗腫瘍効果に必要である. Cancer Research. 71(16). 5445–5454. 2 indexed citations

9.

Sun, Jingjing, Derek Ng Tang, Tihui Fu, & Padmanee Sharma. (2011). Identification of Human Regulatory T Cells in the Setting of T-Cell Activation and Anti–CTLA-4 Immunotherapy on the Basis of Expression of Latency-Associated Peptide. Cancer Discovery. 2(2). 122–130. 23 indexed citations

10.

Li, Kang, Yucheng Li, Wenjuan Wu, et al.. (2008). Modulation of Notch Signaling by Antibodies Specific for the Extracellular Negative Regulatory Region of NOTCH3. Journal of Biological Chemistry. 283(12). 8046–8054. 149 indexed citations

11.

Peng, Guangyong, Zhong Guo, Yukiko Kiniwa, et al.. (2005). Toll-Like Receptor 8-Mediated Reversal of CD4 ⁺ Regulatory T Cell Function. Science. 309(5739). 1380–1384. 603 indexed citations breakdown →

12.

Voo, Kui Shin, Guangyong Peng, Zhong Guo, et al.. (2005). Functional Characterization of EBV-Encoded Nuclear Antigen 1–Specific CD4+ Helper and Regulatory T Cells Elicited byIn vitroPeptide Stimulation. Cancer Research. 65(4). 1577–1586. 74 indexed citations

13.

Voo, Kui Shin, Tihui Fu, Helen Y. Wang, et al.. (2004). Evidence for the Presentation of Major Histocompatibility Complex Class I–restricted Epstein-Barr Virus Nuclear Antigen 1 Peptides to CD8+ T Lymphocytes. The Journal of Experimental Medicine. 199(4). 459–470. 120 indexed citations

14.

Herbert, Lynn M., Joseph F. Grosso, Tihui Fu, et al.. (2004). A Unique Mucin Immunoenhancing Peptide with Antitumor Properties. Cancer Research. 64(21). 8077–8084. 12 indexed citations

15.

Fu, Tihui, Kui Shin Voo, & Rong‐Fu Wang. (2004). Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo. Journal of Clinical Investigation. 114(4). 542–550. 50 indexed citations

16.

Fu, Tihui, Kui Shin Voo, & Rongfu Wang. (2004). Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo. Journal of Clinical Investigation. 114(4). 542–550. 7 indexed citations

17.

Wang, Helen Y., Tihui Fu, Gang Wang, et al.. (2002). Induction of CD4+ T cell–dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. Journal of Clinical Investigation. 109(11). 1463–1470. 78 indexed citations

18.

Voo, Kui Shin, et al.. (2002). Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.. PubMed. 62(24). 7195–9. 50 indexed citations

19.

Wang, Helen Y., Tihui Fu, Gang Wang, et al.. (2002). Induction of CD4+ T cell–dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells. Journal of Clinical Investigation. 109(11). 1463–1470. 18 indexed citations

20.

Fu, Tihui, Yuan Shen, & Shigeyoshi Fujimoto. (2000). Tumor-specific CD4+ suppressor T-cell clone capable of inhibiting rejection of syngeneic sarcoma in A/J mice. International Journal of Cancer. 87(5). 680–687. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact